<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03155724</url>
  </required_header>
  <id_info>
    <org_study_id>MPP Sub-Study</org_study_id>
    <nct_id>NCT03155724</nct_id>
  </id_info>
  <brief_title>QP ExCELs: MultiPole Pacing (MPP) Sub-Study</brief_title>
  <official_title>QP ExCELs: MultiPole Pacing (MPP) Sub-Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this MultiPole Pacing (MPP) sub-study of the QP ExCELs study is to&#xD;
      demonstrate that the MPP feature is effective by converting a percentage of cardiac&#xD;
      resynchronization therapy (CRT) non-responders to responders. The MPP sub-study is a&#xD;
      single-arm, multi-center, prospective trial within the ongoing QP ExCELs study (NCT02290028).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 19, 2017</start_date>
  <completion_date type="Actual">January 23, 2020</completion_date>
  <primary_completion_date type="Actual">January 23, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac Resynchronization Therapy (CRT) Responder Status With the MPP Feature</measure>
    <time_frame>Enrollment to 6 Months</time_frame>
    <description>Count of participants who are classified as &quot;Improved&quot;, where responder classification is derived from a clinical composite score (CCS) based on changes in New York Heart Association (NYHA) class, Heart Failure (HF) hospitalization, and cardiovascular death.&#xD;
Responder classification at 6 months (evaluated compared to MPP Enrollment Visit) :&#xD;
&quot;Improved&quot;&#xD;
No HF hospitalization or cardiovascular death, AND&#xD;
NYHA class is improved&#xD;
&quot;Unchanged&quot;&#xD;
No HF hospitalization or cardiovascular death, AND&#xD;
NYHA class is unchanged&#xD;
&quot;Worsened&quot;&#xD;
HF hospitalization or cardiovascular death has occurred, OR&#xD;
NYHA class is worsened</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Without MPP System Related Adverse Events Requiring Additional Invasive Intervention to Resolve at 6 Months.</measure>
    <time_frame>Enrollment to 6 Months</time_frame>
    <description>Evaluate adverse events that require additional invasive intervention to resolve specifically related to the MPP feature. These adverse events include any software issues related to MPP programming or any adverse event that occurs while MPP is enabled and that may be attributed to the use of the MPP feature. Outcome was evaluated as an adverse event free-rate (AEFR).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Composite Score (CCS) + Patient Global Assessment (PGA) Responder Status Utilizing a Modified CCS That Incorporates the PGA</measure>
    <time_frame>Enrollment to 6 Months</time_frame>
    <description>Evaluate a modified CCS, determining a responder classification based on changes in NYHA class, PGA, HF hospitalization, and cardiovascular death, where the PGA will ask participantss to assess how their overall status has changed since prior to receiving CRT therapy (markedly better, better, unchanged, worse, markedly worse).&#xD;
Modified responder classification (CCS + PGA) at 6 months (evaluated compared to MPP Enrollment Visit):&#xD;
&quot;Improved&quot;&#xD;
No HF hospitalization or cardiovascular death, AND&#xD;
Neither NYHA class is worsened or PGA is worsened (&quot;worse&quot; or &quot;markedly worse&quot;), AND&#xD;
NYHA class is improved or PGA is improved (&quot;better&quot; or &quot;markedly better&quot;)&#xD;
&quot;Unchanged&quot;&#xD;
No HF hospitalization or cardiovascular death, AND&#xD;
NYHA class is unchanged, AND&#xD;
PGA is unchanged (&quot;unchanged&quot;)&#xD;
&quot;Worsened&quot;&#xD;
HF hospitalization or cardiovascular death has occurred, OR&#xD;
NYHA class is worsened or PGA is worsened (&quot;worse&quot; or &quot;markedly worse&quot;)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CCS Responder Status Utilizing an Expanded Responder Classification</measure>
    <time_frame>Enrollment to 6 Months</time_frame>
    <description>Evaluate a modified CCS with an expanded responder classification where &quot;Improved&quot; and &quot;Unchanged&quot; are considered responders.&#xD;
Responder classification at 6 months (evaluated compared to MPP Enrollment Visit) :&#xD;
&quot;Improved&quot;&#xD;
No HF hospitalization or cardiovascular death, AND&#xD;
NYHA class is improved&#xD;
&quot;Unchanged&quot;&#xD;
No HF hospitalization or cardiovascular death, AND&#xD;
NYHA class is unchanged&#xD;
&quot;Worsened&quot;&#xD;
HF hospitalization or cardiovascular death has occurred, OR&#xD;
NYHA class is worsened</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">53</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>MultiPole Pacing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Traditional biventricular pacing CRT non-responders at the 3 or 6 month QP ExCELs study follow-up.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MultiPole Pacing</intervention_name>
    <description>CRT non-responders are programmed with MultiPole pacing ON.</description>
    <arm_group_label>MultiPole Pacing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Currently enrolled in the ongoing QP ExCELs study&#xD;
&#xD;
          -  Successfully implanted with a BIOTRONIK Ilivia 7 HF-T QP family CRT-D system, or&#xD;
             future-marketed CRT-D system with the MPP feature. Successful implantation is defined&#xD;
             as having at least two LV pacing vectors with a measured pacing threshold of â‰¤ 5.0 V @&#xD;
             any pulse width (allowing for a minimum 2.5 V safety margin) without phrenic nerve&#xD;
             stimulation at the final programmed pacing output at the time of enrollment into the&#xD;
             MPP sub-study.&#xD;
&#xD;
          -  CRT Responder Assessment classification as &quot;Worsened&quot; or &quot;Unchanged&quot;&#xD;
&#xD;
          -  Standard continuous biventricular (BiV) pacing from implant until the 6-Month QP&#xD;
             ExCELs follow-up visit. (Implant to 3-Month QP ExCELs follow-up who qualify due to a&#xD;
             Heart Failure (HF) hospitalization event)&#xD;
&#xD;
          -  Able to understand the nature of the sub-study and give informed consent&#xD;
&#xD;
          -  Available for an additional follow-up visit specific to the MPP sub-study at the&#xD;
             investigational site&#xD;
&#xD;
          -  No evidence of non-compliance to their ongoing commitment in the QP ExCELs study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Have a life expectancy of less than 6 months&#xD;
&#xD;
          -  Expected to receive heart transplantation or ventricular assist device within 6 months&#xD;
&#xD;
          -  Chronic atrial fibrillation&#xD;
&#xD;
          -  Presence of another life-threatening, underlying illness separate from their cardiac&#xD;
             disorder&#xD;
&#xD;
          -  Received MPP pacing prior to enrolment into the MPP sub-study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Thomas Hospital</name>
      <address>
        <city>Fairhope</city>
        <state>Alabama</state>
        <zip>36532</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Bay Electrophysiology</name>
      <address>
        <city>Inglewood</city>
        <state>California</state>
        <zip>90301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisenhower Desert Cardiology</name>
      <address>
        <city>Rancho Mirage</city>
        <state>California</state>
        <zip>92270</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MedStar Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Florida Hospital</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orlando Health Heart Institute</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Florida Hospital Tampa Pepin Heart Institute</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33613</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Piedmont Heart Institute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Chicago Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Parkview Physicians Group - Cardiology</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46845</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Iowa Hospitals and Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kansas Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baptist Health - Lexington</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kentucky</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northeast Cardiology</name>
      <address>
        <city>Bangor</city>
        <state>Maine</state>
        <zip>04401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southcoast Health</name>
      <address>
        <city>Fall River</city>
        <state>Massachusetts</state>
        <zip>02720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Massachusetts Medical School</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan Hospital</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Michigan Heart</name>
      <address>
        <city>Ypsilanti</city>
        <state>Michigan</state>
        <zip>48197</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates of North Mississippi</name>
      <address>
        <city>Tupelo</city>
        <state>Mississippi</state>
        <zip>38801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SSM Health St. Joseph Hospital - St. Charles</name>
      <address>
        <city>Saint Charles</city>
        <state>Missouri</state>
        <zip>63301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Louis Heart and Vascular</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Clinic Cardiology</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Glacier View Medical Research Institute, Cardiology</name>
      <address>
        <city>Kalispell</city>
        <state>Montana</state>
        <zip>59901</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jersey Shore University Medical Center</name>
      <address>
        <city>Neptune</city>
        <state>New Jersey</state>
        <zip>07753</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York Presbyterian Queens</name>
      <address>
        <city>Flushing</city>
        <state>New York</state>
        <zip>11355</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mt. Sinai St. Luke's Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westchester Medical Center</name>
      <address>
        <city>Valhalla</city>
        <state>New York</state>
        <zip>10595</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asheville Cardiology Associates</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Novant Health Winston-Salem Cardiology</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Health Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanford Medical Center - Fargo</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Temple Heart and Vascular Institute</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Upstate Cardiology</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UT Erlanger Cardiology</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fort Worth Heart</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UT Health Science Center</name>
      <address>
        <city>The Woodlands</city>
        <state>Texas</state>
        <zip>77380</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Utah Medical Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UVM Medical</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>May 15, 2017</study_first_submitted>
  <study_first_submitted_qc>May 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 16, 2017</study_first_posted>
  <results_first_submitted>January 18, 2021</results_first_submitted>
  <results_first_submitted_qc>February 16, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 8, 2021</results_first_posted>
  <last_update_submitted>February 16, 2021</last_update_submitted>
  <last_update_submitted_qc>February 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 6, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/24/NCT03155724/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>MultiPole Pacing</title>
          <description>Traditional biventricular pacing CRT non-responders at the 3 or 6 month QP ExCELs study follow-up.&#xD;
MultiPole Pacing: CRT non-responders are programmed with MultiPole pacing ON.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="53"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Study closure</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Baseline data collected from all participants enrolled, when available.</population>
      <group_list>
        <group group_id="B1">
          <title>MultiPole Pacing</title>
          <description>Traditional biventricular pacing CRT non-responders at the 3 or 6 month QP ExCELs study follow-up.&#xD;
MultiPole Pacing: CRT non-responders are programmed with MultiPole pacing ON.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="53"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.3" spread="12.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height</title>
          <units>in</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68.5" spread="4.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>Pounds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="212.7" spread="52.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Cardiac Resynchronization Therapy (CRT) Responder Status With the MPP Feature</title>
        <description>Count of participants who are classified as &quot;Improved&quot;, where responder classification is derived from a clinical composite score (CCS) based on changes in New York Heart Association (NYHA) class, Heart Failure (HF) hospitalization, and cardiovascular death.&#xD;
Responder classification at 6 months (evaluated compared to MPP Enrollment Visit) :&#xD;
&quot;Improved&quot;&#xD;
No HF hospitalization or cardiovascular death, AND&#xD;
NYHA class is improved&#xD;
&quot;Unchanged&quot;&#xD;
No HF hospitalization or cardiovascular death, AND&#xD;
NYHA class is unchanged&#xD;
&quot;Worsened&quot;&#xD;
HF hospitalization or cardiovascular death has occurred, OR&#xD;
NYHA class is worsened</description>
        <time_frame>Enrollment to 6 Months</time_frame>
        <population>Participants who have completed the MultiPole Pacing (MPP) Sub-study 6-Month follow-up visit or experienced a qualifying outcome event as of January 23, 2020.</population>
        <group_list>
          <group group_id="O1">
            <title>MultiPole Pacing</title>
            <description>Traditional biventricular pacing CRT non-responders at the 3 or 6 month QP ExCELs study follow-up.&#xD;
MultiPole Pacing: CRT non-responders are programmed with MultiPole pacing ON.</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiac Resynchronization Therapy (CRT) Responder Status With the MPP Feature</title>
          <description>Count of participants who are classified as &quot;Improved&quot;, where responder classification is derived from a clinical composite score (CCS) based on changes in New York Heart Association (NYHA) class, Heart Failure (HF) hospitalization, and cardiovascular death.&#xD;
Responder classification at 6 months (evaluated compared to MPP Enrollment Visit) :&#xD;
&quot;Improved&quot;&#xD;
No HF hospitalization or cardiovascular death, AND&#xD;
NYHA class is improved&#xD;
&quot;Unchanged&quot;&#xD;
No HF hospitalization or cardiovascular death, AND&#xD;
NYHA class is unchanged&#xD;
&quot;Worsened&quot;&#xD;
HF hospitalization or cardiovascular death has occurred, OR&#xD;
NYHA class is worsened</description>
          <population>Participants who have completed the MultiPole Pacing (MPP) Sub-study 6-Month follow-up visit or experienced a qualifying outcome event as of January 23, 2020.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unchanged</title>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Worsened</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>The primary endpoint 1 hypothesis was evaluated by performing an exact, binomial test comparing the binomial proportion of 'improved' patients to 3.0% with power of 80% and type 1 error (alpha) of 0.0224. A pre-planned interim analysis at 45 patients required a type 1 error (alpha) of 0.0026 to demonstrate significance.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Exact, binomial, one-sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Without MPP System Related Adverse Events Requiring Additional Invasive Intervention to Resolve at 6 Months.</title>
        <description>Evaluate adverse events that require additional invasive intervention to resolve specifically related to the MPP feature. These adverse events include any software issues related to MPP programming or any adverse event that occurs while MPP is enabled and that may be attributed to the use of the MPP feature. Outcome was evaluated as an adverse event free-rate (AEFR).</description>
        <time_frame>Enrollment to 6 Months</time_frame>
        <population>Evaluable participants for Secondary Endpoint 1 include all participants who have been enrolled into the MPP Sub-Study.</population>
        <group_list>
          <group group_id="O1">
            <title>MultiPole Pacing</title>
            <description>Traditional biventricular pacing CRT non-responders at the 3 or 6 month QP ExCELs study follow-up.&#xD;
MultiPole Pacing: CRT non-responders are programmed with MultiPole pacing ON.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Without MPP System Related Adverse Events Requiring Additional Invasive Intervention to Resolve at 6 Months.</title>
          <description>Evaluate adverse events that require additional invasive intervention to resolve specifically related to the MPP feature. These adverse events include any software issues related to MPP programming or any adverse event that occurs while MPP is enabled and that may be attributed to the use of the MPP feature. Outcome was evaluated as an adverse event free-rate (AEFR).</description>
          <population>Evaluable participants for Secondary Endpoint 1 include all participants who have been enrolled into the MPP Sub-Study.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="93.28" upper_limit="100.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Clinical Composite Score (CCS) + Patient Global Assessment (PGA) Responder Status Utilizing a Modified CCS That Incorporates the PGA</title>
        <description>Evaluate a modified CCS, determining a responder classification based on changes in NYHA class, PGA, HF hospitalization, and cardiovascular death, where the PGA will ask participantss to assess how their overall status has changed since prior to receiving CRT therapy (markedly better, better, unchanged, worse, markedly worse).&#xD;
Modified responder classification (CCS + PGA) at 6 months (evaluated compared to MPP Enrollment Visit):&#xD;
&quot;Improved&quot;&#xD;
No HF hospitalization or cardiovascular death, AND&#xD;
Neither NYHA class is worsened or PGA is worsened (&quot;worse&quot; or &quot;markedly worse&quot;), AND&#xD;
NYHA class is improved or PGA is improved (&quot;better&quot; or &quot;markedly better&quot;)&#xD;
&quot;Unchanged&quot;&#xD;
No HF hospitalization or cardiovascular death, AND&#xD;
NYHA class is unchanged, AND&#xD;
PGA is unchanged (&quot;unchanged&quot;)&#xD;
&quot;Worsened&quot;&#xD;
HF hospitalization or cardiovascular death has occurred, OR&#xD;
NYHA class is worsened or PGA is worsened (&quot;worse&quot; or &quot;markedly worse&quot;)</description>
        <time_frame>Enrollment to 6 Months</time_frame>
        <population>Participants who have completed the MPP Sub-Study 6-Month follow-up visit or experienced a qualifying outcome event as of January 23, 2020.</population>
        <group_list>
          <group group_id="O1">
            <title>MultiPole Pacing</title>
            <description>Traditional biventricular pacing CRT non-responders at the 3 or 6 month QP ExCELs study follow-up.&#xD;
MultiPole Pacing: CRT non-responders are programmed with MultiPole pacing ON.</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Composite Score (CCS) + Patient Global Assessment (PGA) Responder Status Utilizing a Modified CCS That Incorporates the PGA</title>
          <description>Evaluate a modified CCS, determining a responder classification based on changes in NYHA class, PGA, HF hospitalization, and cardiovascular death, where the PGA will ask participantss to assess how their overall status has changed since prior to receiving CRT therapy (markedly better, better, unchanged, worse, markedly worse).&#xD;
Modified responder classification (CCS + PGA) at 6 months (evaluated compared to MPP Enrollment Visit):&#xD;
&quot;Improved&quot;&#xD;
No HF hospitalization or cardiovascular death, AND&#xD;
Neither NYHA class is worsened or PGA is worsened (&quot;worse&quot; or &quot;markedly worse&quot;), AND&#xD;
NYHA class is improved or PGA is improved (&quot;better&quot; or &quot;markedly better&quot;)&#xD;
&quot;Unchanged&quot;&#xD;
No HF hospitalization or cardiovascular death, AND&#xD;
NYHA class is unchanged, AND&#xD;
PGA is unchanged (&quot;unchanged&quot;)&#xD;
&quot;Worsened&quot;&#xD;
HF hospitalization or cardiovascular death has occurred, OR&#xD;
NYHA class is worsened or PGA is worsened (&quot;worse&quot; or &quot;markedly worse&quot;)</description>
          <population>Participants who have completed the MPP Sub-Study 6-Month follow-up visit or experienced a qualifying outcome event as of January 23, 2020.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unchanged</title>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Worsened</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>CCS Responder Status Utilizing an Expanded Responder Classification</title>
        <description>Evaluate a modified CCS with an expanded responder classification where &quot;Improved&quot; and &quot;Unchanged&quot; are considered responders.&#xD;
Responder classification at 6 months (evaluated compared to MPP Enrollment Visit) :&#xD;
&quot;Improved&quot;&#xD;
No HF hospitalization or cardiovascular death, AND&#xD;
NYHA class is improved&#xD;
&quot;Unchanged&quot;&#xD;
No HF hospitalization or cardiovascular death, AND&#xD;
NYHA class is unchanged&#xD;
&quot;Worsened&quot;&#xD;
HF hospitalization or cardiovascular death has occurred, OR&#xD;
NYHA class is worsened</description>
        <time_frame>Enrollment to 6 Months</time_frame>
        <population>Participants who have completed the MPP Sub-Study 6-Month follow-up visit or experienced a qualifying outcome event as of January 23, 2020.</population>
        <group_list>
          <group group_id="O1">
            <title>MultiPole Pacing</title>
            <description>Traditional biventricular pacing CRT non-responders at the 3 or 6 month QP ExCELs study follow-up.&#xD;
MultiPole Pacing: CRT non-responders are programmed with MultiPole pacing ON.</description>
          </group>
        </group_list>
        <measure>
          <title>CCS Responder Status Utilizing an Expanded Responder Classification</title>
          <description>Evaluate a modified CCS with an expanded responder classification where &quot;Improved&quot; and &quot;Unchanged&quot; are considered responders.&#xD;
Responder classification at 6 months (evaluated compared to MPP Enrollment Visit) :&#xD;
&quot;Improved&quot;&#xD;
No HF hospitalization or cardiovascular death, AND&#xD;
NYHA class is improved&#xD;
&quot;Unchanged&quot;&#xD;
No HF hospitalization or cardiovascular death, AND&#xD;
NYHA class is unchanged&#xD;
&quot;Worsened&quot;&#xD;
HF hospitalization or cardiovascular death has occurred, OR&#xD;
NYHA class is worsened</description>
          <population>Participants who have completed the MPP Sub-Study 6-Month follow-up visit or experienced a qualifying outcome event as of January 23, 2020.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Responder</title>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Non-Responder</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <desc>Sites were required to report any cardiovascular hospitalizations and any other hospitalizations in which cardiovascular symptoms occur on or before the date of the MPP 6-Month follow-up. These hospitalizations were categorized as Heart Failure Hospitalization, Non-Heart Failure Hospitalization, or if applicable, Non-system related/non-protocol defined. Extracardiac stimulation was assessed/categorized however other specific adverse event terms were not assessed.</desc>
      <group_list>
        <group group_id="E1">
          <title>MultiPole Pacing</title>
          <description>Traditional biventricular pacing CRT non-responders at the 3 or 6 month QP ExCELs study follow-up.&#xD;
MultiPole Pacing: CRT non-responders are programmed with MultiPole pacing ON.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Heart Failure Hospitalization</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Non-Heart failure Hospitalization</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Non-system related/ Non Protocol-defined</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="53"/>
              </event>
              <event>
                <sub_title>Extracardiac stimulation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="53"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Studies Engineer Manager</name_or_title>
      <organization>BIOTRONIK</organization>
      <phone>800-547-0394</phone>
      <email>crystal.miller@biotronik.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

